<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
	<entry dataset="Swiss-Prot" created="1990-11-01" modified="2013-07-24"
		version="172">
		<accession>P15056</accession>
		<accession>A4D1T4</accession>
		<accession>B6HY61</accession>
		<accession>B6HY62</accession>
		<accession>B6HY63</accession>
		<accession>B6HY64</accession>
		<accession>B6HY65</accession>
		<accession>B6HY66</accession>
		<accession>Q13878</accession>
		<accession>Q3MIN6</accession>
		<accession>Q9UDP8</accession>
		<accession>Q9Y6T3</accession>
		<name>BRAF_HUMAN</name>
		<protein>
			<recommendedName>
				<fullName>Serine/threonine-protein kinase B-raf</fullName>
				<ecNumber>2.7.11.1</ecNumber>
			</recommendedName>
			<alternativeName>
				<fullName>Proto-oncogene B-Raf</fullName>
			</alternativeName>
			<alternativeName>
				<fullName>p94</fullName>
			</alternativeName>
			<alternativeName>
				<fullName>v-Raf murine sarcoma viral oncogene homolog B1</fullName>
			</alternativeName>
		</protein>
		<gene>
			<name type="primary">BRAF</name>
			<name type="synonym">BRAF1</name>
			<name type="synonym">RAFB1</name>
		</gene>
		<organism>
			<name type="scientific">Homo sapiens</name>
			<name type="common">Human</name>
			<dbReference type="NCBI Taxonomy" id="9606" />
			<lineage>
				<taxon>Eukaryota</taxon>
				<taxon>Metazoa</taxon>
				<taxon>Chordata</taxon>
				<taxon>Craniata</taxon>
				<taxon>Vertebrata</taxon>
				<taxon>Euteleostomi</taxon>
				<taxon>Mammalia</taxon>
				<taxon>Eutheria</taxon>
				<taxon>Euarchontoglires</taxon>
				<taxon>Primates</taxon>
				<taxon>Haplorrhini</taxon>
				<taxon>Catarrhini</taxon>
				<taxon>Hominidae</taxon>
				<taxon>Homo</taxon>
			</lineage>
		</organism>
		<reference key="1">
			<citation type="journal article" date="1992" name="Mol. Cell. Biol."
				volume="12" first="3733" last="3742">
				<title>95-kilodalton B-Raf serine/threonine kinase: identification
					of the protein and its major autophosphorylation site.</title>
				<authorList>
					<person name="Stephens R.M." />
					<person name="Sithanandam G." />
					<person name="Copeland T.D." />
					<person name="Kaplan D.R." />
					<person name="Rapp U.R." />
					<person name="Morrison D.K." />
				</authorList>
				<dbReference type="PubMed" id="1508179" />
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
			<scope>PARTIAL PROTEIN SEQUENCE</scope>
			<scope>PHOSPHORYLATION AT THR-373</scope>
			<source>
				<tissue>Testis</tissue>
			</source>
		</reference>
		<reference key="2">
			<citation type="submission" date="2004-01"
				db="EMBL/GenBank/DDBJ databases">
				<authorList>
					<person name="Albert S." />
					<person name="Wixler L." />
					<person name="Rapp U.R." />
				</authorList>
			</citation>
			<scope>SEQUENCE REVISION TO 31-33</scope>
		</reference>
		<reference key="3">
			<citation type="submission" date="2008-03"
				db="EMBL/GenBank/DDBJ databases">
				<authorList>
					<consortium name="NIEHS SNPs program" />
				</authorList>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
		</reference>
		<reference key="4">
			<citation type="journal article" date="2003" name="Science"
				volume="300" first="767" last="772">
				<title>Human chromosome 7: DNA sequence and biology.</title>
				<authorList>
					<person name="Scherer S.W." />
				</authorList>
				<dbReference type="PubMed" id="12690205" />
				<dbReference type="DOI" id="10.1126/science.1083423" />
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
		</reference>
		<reference key="5">
			<citation type="journal article" date="2003" name="Nature"
				volume="424" first="157" last="164">
				<title>The DNA sequence of human chromosome 7.</title>
				<authorList>
					<person name="Hillier L.W." />
				</authorList>
				<dbReference type="PubMed" id="12853948" />
				<dbReference type="DOI" id="10.1038/nature01782" />
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
		</reference>
		<reference key="6">
			<citation type="journal article" date="2004" name="Genome Res."
				volume="14" first="2121" last="2127">
				<title>The status, quality, and expansion of the NIH full-length
					cDNA project: the Mammalian Gene Collection (MGC).</title>
				<authorList>
					<consortium name="The MGC Project Team" />
				</authorList>
				<dbReference type="PubMed" id="15489334" />
				<dbReference type="DOI" id="10.1101/gr.2596504" />
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
			<source>
				<tissue>Liver</tissue>
			</source>
		</reference>
		<reference key="7">
			<citation type="journal article" date="1992" name="Oncogene"
				volume="7" first="1657" last="1660">
				<title>Chromosomal assignment of two human B-raf(Rmil)
					proto-oncogene loci: B-raf-1 encoding the p94Braf/Rmil and B-raf-2,
					a processed pseudogene.</title>
				<authorList>
					<person name="Eychene A." />
					<person name="Barnier J.V." />
					<person name="Apiou F." />
					<person name="Dutrillaux B." />
					<person name="Calothy G." />
				</authorList>
				<dbReference type="PubMed" id="1630826" />
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-200</scope>
			<source>
				<tissue>Placenta</tissue>
			</source>
		</reference>
		<reference key="8">
			<citation type="submission" date="2008-12" db="UniProtKB">
				<authorList>
					<person name="Bienvenut W.V." />
					<person name="Boldt K." />
					<person name="von Kriegsheim A.F." />
					<person name="Zebisch A." />
					<person name="Kolch W." />
				</authorList>
			</citation>
			<scope>PROTEIN SEQUENCE OF 2-51; 56-95; 151-158; 189-199; 253-260;
				294-354; 361-424; 444-507; 510-522; 559-570; 579-626; 663-680;
				692-698; 702-719; 727-735 AND 753-766</scope>
			<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
			<scope>ACETYLATION AT ALA-2</scope>
			<scope>PHOSPHORYLATION AT SER-365; THR-396; SER-399; THR-401 AND
				SER-729</scope>
			<scope>MASS SPECTROMETRY</scope>
			<source>
				<tissue>Colon carcinoma</tissue>
				<tissue>Hepatoma</tissue>
			</source>
		</reference>
		<reference key="9">
			<citation type="journal article" date="1990" name="Oncogene"
				volume="5" first="1775" last="1780">
				<title>Complete coding sequence of a human B-raf cDNA and detection
					of B-raf protein kinase with isozyme specific antibodies.</title>
				<authorList>
					<person name="Sithanandam G." />
					<person name="Kolch W." />
					<person name="Duh F.-M." />
					<person name="Rapp U.R." />
				</authorList>
				<dbReference type="PubMed" id="2284096" />
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 117-766</scope>
			<source>
				<tissue>Testis</tissue>
			</source>
		</reference>
		<reference key="10">
			<citation type="journal article" date="2008" name="Cancer Res."
				volume="68" first="8673" last="8677">
				<title>Tandem duplication producing a novel oncogenic BRAF fusion
					gene defines the majority of pilocytic astrocytomas.</title>
				<authorList>
					<person name="Jones D.T.W." />
				</authorList>
				<dbReference type="PubMed" id="18974108" />
				<dbReference type="DOI" id="10.1158/0008-5472.CAN-08-2097" />
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 381-766</scope>
			<scope>DISEASE</scope>
			<scope>CHROMOSOMAL REARRANGEMENT</scope>
			<source>
				<tissue>Brain</tissue>
			</source>
		</reference>
		<reference key="11">
			<citation type="journal article" date="1988" name="Mol. Cell. Biol."
				volume="8" first="2651" last="2654">
				<title>B-raf, a new member of the raf family, is activated by DNA
					rearrangement.</title>
				<authorList>
					<person name="Ikawa S." />
				</authorList>
				<dbReference type="PubMed" id="3043188" />
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 439-766</scope>
		</reference>
		<reference key="12">
			<citation type="journal article" date="2001" name="J. Biol. Chem."
				volume="276" first="31620" last="31626">
				<title>Serum- and glucocorticoid-inducible kinase SGK phosphorylates
					and negatively regulates B-Raf.</title>
				<authorList>
					<person name="Zhang B.H." />
					<person name="Tang E.D." />
					<person name="Zhu T." />
					<person name="Greenberg M.E." />
					<person name="Vojtek A.B." />
					<person name="Guan K.L." />
				</authorList>
				<dbReference type="PubMed" id="11410590" />
				<dbReference type="DOI" id="10.1074/jbc.M102808200" />
			</citation>
			<scope>PHOSPHORYLATION AT SER-365 BY SGK1</scope>
		</reference>
		<reference key="13">
			<citation type="journal article" date="2006" name="Nat. Biotechnol."
				volume="24" first="1285" last="1292">
				<title>A probability-based approach for high-throughput protein
					phosphorylation analysis and site localization.</title>
				<authorList>
					<person name="Beausoleil S.A." />
					<person name="Villen J." />
					<person name="Gerber S.A." />
					<person name="Rush J." />
					<person name="Gygi S.P." />
				</authorList>
				<dbReference type="PubMed" id="16964243" />
				<dbReference type="DOI" id="10.1038/nbt1240" />
			</citation>
			<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401</scope>
			<scope>MASS SPECTROMETRY</scope>
			<source>
				<tissue>Cervix carcinoma</tissue>
			</source>
		</reference>
		<reference key="14">
			<citation type="journal article" date="2008" name="Mol. Cell"
				volume="31" first="438" last="448">
				<title>Kinase-selective enrichment enables quantitative
					phosphoproteomics of the kinome across the cell cycle.</title>
				<authorList>
					<person name="Daub H." />
				</authorList>
				<dbReference type="PubMed" id="18691976" />
				<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007" />
			</citation>
			<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
			</scope>
			<source>
				<tissue>Cervix carcinoma</tissue>
			</source>
		</reference>
		<reference key="15">
			<citation type="journal article" date="2008"
				name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762"
				last="10767">
				<title>A quantitative atlas of mitotic phosphorylation.</title>
				<authorList>
					<person name="Dephoure N." />
					<person name="Zhou C." />
					<person name="Villen J." />
					<person name="Beausoleil S.A." />
					<person name="Bakalarski C.E." />
					<person name="Elledge S.J." />
					<person name="Gygi S.P." />
				</authorList>
				<dbReference type="PubMed" id="18669648" />
				<dbReference type="DOI" id="10.1073/pnas.0805139105" />
			</citation>
			<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401; SER-446;
				SER-447 AND SER-729</scope>
			<scope>MASS SPECTROMETRY</scope>
			<source>
				<tissue>Cervix carcinoma</tissue>
			</source>
		</reference>
		<reference key="16">
			<citation type="journal article" date="2009" name="J. Biol. Chem."
				volume="284" first="29559" last="29570">
				<title>Diacylglycerol kinase eta augments C-Raf activity and
					B-Raf/C-Raf heterodimerization.</title>
				<authorList>
					<person name="Yasuda S." />
					<person name="Kai M." />
					<person name="Imai S." />
					<person name="Takeishi K." />
					<person name="Taketomi A." />
					<person name="Toyota M." />
					<person name="Kanoh H." />
					<person name="Sakane F." />
				</authorList>
				<dbReference type="PubMed" id="19710016" />
				<dbReference type="DOI" id="10.1074/jbc.M109.043604" />
			</citation>
			<scope>SUBUNIT</scope>
			<scope>INTERACTION WITH DGKH</scope>
			<scope>PHOSPHORYLATION AT THR-753 BY MAPK1</scope>
		</reference>
		<reference key="17">
			<citation type="journal article" date="2009" name="Sci. Signal."
				volume="2" first="RA46" last="RA46">
				<title>Quantitative phosphoproteomic analysis of T cell receptor
					signaling reveals system-wide modulation of protein-protein
					interactions.</title>
				<authorList>
					<person name="Mayya V." />
					<person name="Lundgren D.H." />
					<person name="Hwang S.-I." />
					<person name="Rezaul K." />
					<person name="Wu L." />
					<person name="Eng J.K." />
					<person name="Rodionov V." />
					<person name="Han D.K." />
				</authorList>
				<dbReference type="PubMed" id="19690332" />
				<dbReference type="DOI" id="10.1126/scisignal.2000007" />
			</citation>
			<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
			</scope>
			<source>
				<tissue>Leukemic T-cell</tissue>
			</source>
		</reference>
		<reference key="18">
			<citation type="journal article" date="2010" name="Sci. Signal."
				volume="3" first="RA3" last="RA3">
				<title>Quantitative phosphoproteomics reveals widespread full
					phosphorylation site occupancy during mitosis.</title>
				<authorList>
					<person name="Olsen J.V." />
				</authorList>
				<dbReference type="PubMed" id="20068231" />
				<dbReference type="DOI" id="10.1126/scisignal.2000475" />
			</citation>
			<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
			</scope>
			<source>
				<tissue>Cervix carcinoma</tissue>
			</source>
		</reference>
		<reference key="19">
			<citation type="journal article" date="2011" name="Sci. Signal."
				volume="4" first="RA58" last="RA58">
				<title>Protein arginine methyltransferase 5 regulates ERK1/2 signal
					transduction amplitude and cell fate through CRAF.</title>
				<authorList>
					<person name="Andreu-Perez P." />
				</authorList>
				<dbReference type="PubMed" id="21917714" />
				<dbReference type="DOI" id="10.1126/scisignal.2001936" />
			</citation>
			<scope>INTERACTION WITH PRMT5</scope>
			<scope>METHYLATION AT ARG-671</scope>
			<scope>CHARACTERIZATION OF VARIANT CRC GLU-600</scope>
			<scope>MUTAGENESIS OF ARG-671</scope>
		</reference>
		<reference key="20">
			<citation type="journal article" date="2011" name="Sci. Signal."
				volume="4" first="RS3" last="RS3">
				<title>System-wide temporal characterization of the proteome and
					phosphoproteome of human embryonic stem cell differentiation.
				</title>
				<authorList>
					<person name="Rigbolt K.T." />
					<person name="Prokhorova T.A." />
					<person name="Akimov V." />
					<person name="Henningsen J." />
					<person name="Johansen P.T." />
					<person name="Kratchmarova I." />
					<person name="Kassem M." />
					<person name="Mann M." />
					<person name="Olsen J.V." />
					<person name="Blagoev B." />
				</authorList>
				<dbReference type="PubMed" id="21406692" />
				<dbReference type="DOI" id="10.1126/scisignal.2001570" />
			</citation>
			<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729</scope>
			<scope>MASS SPECTROMETRY</scope>
		</reference>
		<reference key="21">
			<citation type="journal article" date="2012" name="J. Biol. Chem."
				volume="287" first="24017" last="24025">
				<title>RING finger protein 149 is an E3 ubiquitin ligase active on
					wild-type BRAF.</title>
				<authorList>
					<person name="Hong S.W." />
					<person name="Jin D.H." />
					<person name="Shin J.S." />
					<person name="Moon J.H." />
					<person name="Na Y.S." />
					<person name="Jung K.A." />
					<person name="Kim S.M." />
					<person name="Kim J.C." />
					<person name="Kim K.P." />
					<person name="Hong Y.S." />
					<person name="Lee J.L." />
					<person name="Choi E.K." />
					<person name="Lee J.S." />
					<person name="Kim T.W." />
				</authorList>
				<dbReference type="PubMed" id="22628551" />
				<dbReference type="DOI" id="10.1074/jbc.M111.319822" />
			</citation>
			<scope>UBIQUITINATION BY RNF149</scope>
		</reference>
		<reference key="22">
			<citation type="journal article" date="2008"
				name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="3041" last="3046">
				<title>Discovery of a selective inhibitor of oncogenic B-Raf kinase
					with potent antimelanoma activity.</title>
				<authorList>
					<person name="Tsai J." />
				</authorList>
				<dbReference type="PubMed" id="18287029" />
				<dbReference type="DOI" id="10.1073/pnas.0711741105" />
			</citation>
			<scope>X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) OF 444-719 IN COMPLEX
				WITH INHIBITOR</scope>
		</reference>
		<reference key="23">
			<citation type="journal article" date="2002" name="Cancer Res."
				volume="62" first="7001" last="7003">
				<title>Missense mutations of the BRAF gene in human lung
					adenocarcinoma.</title>
				<authorList>
					<person name="Naoki K." />
					<person name="Chen T.-H." />
					<person name="Richards W.G." />
					<person name="Sugarbaker D.J." />
					<person name="Meyerson M." />
				</authorList>
				<dbReference type="PubMed" id="12460919" />
			</citation>
			<scope>VARIANTS LNCR VAL-466 AND ARG-597</scope>
		</reference>
		<reference key="24">
			<citation type="journal article" date="2002" name="Nature"
				volume="417" first="949" last="954">
				<title>Mutations of the BRAF gene in human cancer.</title>
				<authorList>
					<person name="Davies H." />
				</authorList>
				<dbReference type="PubMed" id="12068308" />
				<dbReference type="DOI" id="10.1038/nature00766" />
			</citation>
			<scope>VARIANTS CANCER GLU-464; VAL-464; ALA-466; GLU-466; VAL-466;
				ALA-469; GLU-469; LYS-586; LEU-595; ARG-596; ARG-597; VAL-597;
				GLU-600 AND ASP-600</scope>
			<scope>CHARACTERIZATION OF VARIANTS CANCER VAL-464; ALA-469; VAL-597
				AND GLU-600</scope>
		</reference>
		<reference key="25">
			<citation type="journal article" date="2002" name="Nature"
				volume="418" first="934" last="934">
				<title>Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.
				</title>
				<authorList>
					<person name="Rajagopalan H." />
				</authorList>
				<dbReference type="PubMed" id="12198537" />
				<dbReference type="DOI" id="10.1038/418934a" />
			</citation>
			<scope>VARIANTS CRC ILE-462; SER-463; GLU-464; GLU-600 AND GLU-601
			</scope>
		</reference>
		<reference key="26">
			<citation type="journal article" date="2003" name="Br. J. Cancer"
				volume="89" first="1958" last="1960">
				<title>BRAF mutations in non-Hodgkin's lymphoma.</title>
				<authorList>
					<person name="Lee J.W." />
				</authorList>
				<dbReference type="PubMed" id="14612909" />
				<dbReference type="DOI" id="10.1038/sj.bjc.6601371" />
			</citation>
			<scope>VARIANTS NHL ALA-469; ARG-469 AND GLY-594</scope>
		</reference>
		<reference key="27">
			<citation type="journal article" date="2003" name="Cancer Res."
				volume="63" first="5198" last="5202">
				<title>Suppression of BRAF(V599E) in human melanoma abrogates
					transformation.</title>
				<authorList>
					<person name="Hingorani S.R." />
					<person name="Jacobetz M.A." />
					<person name="Robertson G.P." />
					<person name="Herlyn M." />
					<person name="Tuveson D.A." />
				</authorList>
				<dbReference type="PubMed" id="14500344" />
			</citation>
			<scope>CHARACTERIZATION OF VARIANT MELANOMA GLU-600</scope>
		</reference>
		<reference key="28">
			<citation type="journal article" date="2006" name="Nat. Genet."
				volume="38" first="294" last="296">
				<title>Germline KRAS and BRAF mutations in cardio-facio-cutaneous
					syndrome.</title>
				<authorList>
					<person name="Niihori T." />
				</authorList>
				<dbReference type="PubMed" id="16474404" />
				<dbReference type="DOI" id="10.1038/ng1749" />
			</citation>
			<scope>VARIANTS CFC SYNDROME PRO-246; ARG-257; GLU-469; PHE-485;
				GLU-499; LYS-501; GLY-501 AND ASP-581</scope>
		</reference>
		<reference key="29">
			<citation type="journal article" date="2006" name="Science"
				volume="314" first="268" last="274">
				<title>The consensus coding sequences of human breast and colorectal
					cancers.</title>
				<authorList>
					<person name="Sjoeblom T." />
				</authorList>
				<dbReference type="PubMed" id="16959974" />
				<dbReference type="DOI" id="10.1126/science.1133427" />
			</citation>
			<scope>VARIANT [LARGE SCALE ANALYSIS] GLU-600</scope>
		</reference>
		<reference key="30">
			<citation type="journal article" date="2006" name="Science"
				volume="311" first="1287" last="1290">
				<title>Germline mutations in genes within the MAPK pathway cause
					cardio-facio-cutaneous syndrome.</title>
				<authorList>
					<person name="Rodriguez-Viciana P." />
					<person name="Tetsu O." />
					<person name="Tidyman W.E." />
					<person name="Estep A.L." />
					<person name="Conger B.A." />
					<person name="Cruz M.S." />
					<person name="McCormick F." />
					<person name="Rauen K.A." />
				</authorList>
				<dbReference type="PubMed" id="16439621" />
				<dbReference type="DOI" id="10.1126/science.1124642" />
			</citation>
			<scope>VARIANTS CFC SYNDROME ARG-257; ALA-467; SER-468; GLU-469;
				PHE-485; GLU-499; LYS-501; GLY-501; ASP-581; LEU-595 AND VAL-596
			</scope>
		</reference>
		<reference key="31">
			<citation type="journal article" date="2007" name="Nature"
				volume="446" first="153" last="158">
				<title>Patterns of somatic mutation in human cancer genomes.</title>
				<authorList>
					<person name="Greenman C." />
				</authorList>
				<dbReference type="PubMed" id="17344846" />
				<dbReference type="DOI" id="10.1038/nature05610" />
			</citation>
			<scope>VARIANTS [LARGE SCALE ANALYSIS] SER-301; ALA-469; VAL-469;
				SER-581; ARG-596; ARG-597; VAL-597; GLU-600; GLU-600 AND GLU-600
			</scope>
		</reference>
		<reference key="32">
			<citation type="journal article" date="2008" name="Clin. Genet."
				volume="73" first="62" last="70">
				<title>Mutation and phenotypic spectrum in patients with
					cardio-facio-cutaneous and Costello syndrome.</title>
				<authorList>
					<person name="Schulz A.L." />
				</authorList>
				<dbReference type="PubMed" id="18042262" />
				<dbReference type="DOI" id="10.1111/j.1399-0004.2007.00931.x" />
			</citation>
			<scope>VARIANTS CFC SYNDROME PRO-241; PRO-244; PRO-246; ARG-257;
				LYS-262; SER-468; GLU-469; GLU-499; ASN-499; ASP-580; ASP-581 AND
				LEU-595</scope>
		</reference>
		<reference key="33">
			<citation type="journal article" date="2009" name="Hum. Mutat."
				volume="30" first="695" last="702">
				<title>Germline BRAF mutations in Noonan, LEOPARD, and
					cardiofaciocutaneous syndromes: molecular diversity and associated
					phenotypic spectrum.</title>
				<authorList>
					<person name="Sarkozy A." />
				</authorList>
				<dbReference type="PubMed" id="19206169" />
				<dbReference type="DOI" id="10.1002/humu.20955" />
			</citation>
			<scope>VARIANT LEOPARD3 PRO-241</scope>
			<scope>VARIANTS NS7 CYS-531 AND VAL-597</scope>
			<scope>VARIANTS CFC SYNDROME PHE-245; PRO-246; ARG-257; LYS-275;
				GLU-469; PHE-485; ASN-499; LYS-501; PRO-525; LEU-595; ARG-599;
				GLN-601; GLU-638 AND ARG-709</scope>
			<scope>VARIANTS ARG-241 AND MET-241</scope>
		</reference>
		<reference key="34">
			<citation type="journal article" date="2013" name="Nat. Genet."
				volume="45" first="136" last="144">
				<title>Germline mutations affecting the proofreading domains of POLE
					and POLD1 predispose to colorectal adenomas and carcinomas.</title>
				<authorList>
					<consortium name="CORGI Consortium" />
					<consortium name="WGS500 Consortium" />
					<person name="Palles C." />
				</authorList>
				<dbReference type="PubMed" id="23263490" />
				<dbReference type="DOI" id="10.1038/ng.2503" />
			</citation>
			<scope>VARIANT CRC GLU-600</scope>
		</reference>
		<comment type="function">
			<text>Involved in the transduction of mitogenic signals from the cell
				membrane to the nucleus. May play a role in the postsynaptic
				responses of hippocampal neuron.</text>
		</comment>
		<comment type="catalytic activity">
			<text>ATP + a protein = ADP + a phosphoprotein.</text>
		</comment>
		<comment type="cofactor">
			<text>Binds 2 zinc ions per subunit (By similarity).</text>
		</comment>
		<comment type="enzyme regulation">
			<text>Activity is increased by EGF and HGF.</text>
		</comment>
		<comment type="subunit">
			<text evidence="1 2">Monomer. Homodimer. Heterodimerizes with RAF1,
				and the heterodimer possesses a highly increased kinase activity
				compared to the respective homodimers or monomers.
				Heterodimerization is mitogen-regulated and enhanced by 14-3-3
				proteins. MAPK1/ERK2 activation can induce a negative feedback that
				promotes the dissociation of the heterodimer by phosphorylating BRAF
				at Thr-753. Found in a complex with at least BRAF, HRAS1, MAP2K1,
				MAPK3 and RGS14. Interacts with RIT1. Interacts (via N-terminus)
				with RGS14 (via RBD domains); the interaction mediates the formation
				of a ternary complex with RAF1, a ternary complex inhibited by GNAI1
				(By similarity). Interacts with DGKH. Interacts with PRMT5.</text>
		</comment>
		<comment type="interaction">
			<interactant intactId="EBI-365980" />
			<interactant intactId="EBI-352572">
				<id>P08238</id>
				<label>HSP90AB1</label>
			</interactant>
			<organismsDiffer>false</organismsDiffer>
			<experiments>2</experiments>
		</comment>
		<comment type="interaction">
			<interactant intactId="EBI-365980" />
			<interactant intactId="EBI-365996">
				<id>P04049</id>
				<label>RAF1</label>
			</interactant>
			<organismsDiffer>false</organismsDiffer>
			<experiments>30</experiments>
		</comment>
		<comment type="interaction">
			<interactant intactId="EBI-365980" />
			<interactant intactId="EBI-357631">
				<id>Q13114</id>
				<label>TRAF3</label>
			</interactant>
			<organismsDiffer>false</organismsDiffer>
			<experiments>2</experiments>
		</comment>
		<comment type="subcellular location">
			<subcellularLocation>
				<location status="by similarity">Nucleus</location>
			</subcellularLocation>
			<subcellularLocation>
				<location>Cytoplasm</location>
			</subcellularLocation>
			<subcellularLocation>
				<location status="by similarity">Cell membrane</location>
			</subcellularLocation>
			<text>Colocalizes with RGS14 and RAF1 in both the cytoplasm and
				membranes (By similarity).</text>
		</comment>
		<comment type="tissue specificity">
			<text>Brain and testis.</text>
		</comment>
		<comment type="PTM">
			<text>Phosphorylation at Ser-365 by SGK1 inhibits its activity.
			</text>
		</comment>
		<comment type="PTM">
			<text evidence="2">Methylation at Arg-671 decreases stability and
				kinase activity.</text>
		</comment>
		<comment type="PTM">
			<text evidence="3">Ubiquitinated by RNF149; which leads to
				proteasomal degradation.</text>
		</comment>
		<comment type="disease" evidence="4">
			<text>Defects in BRAF are found in a wide range of cancers.</text>
		</comment>
		<comment type="disease" evidence="4">
			<disease id="DI-01359">
				<name>Colorectal cancer</name>
				<acronym>CRC</acronym>
				<description>A complex disease characterized by malignant lesions
					arising from the inner wall of the large intestine (the colon) and
					the rectum. Genetic alterations are often associated with
					progression from premalignant lesion (adenoma) to invasive
					adenocarcinoma. Risk factors for cancer of the colon and rectum
					include colon polyps, long-standing ulcerative colitis, and genetic
					family history.</description>
				<dbReference type="MIM" id="114500" />
			</disease>
			<text>The disease may be caused by mutations affecting the gene
				represented in this entry.</text>
		</comment>
		<comment type="disease" evidence="4 5">
			<disease id="DI-02205">
				<name>Lung cancer</name>
				<acronym>LNCR</acronym>
				<description>A common malignancy affecting tissues of the lung. The
					most common form of lung cancer is non-small cell lung cancer
					(NSCLC) that can be divided into 3 major histologic subtypes:
					squamous cell carcinoma, adenocarcinoma, and large cell lung
					cancer. NSCLC is often diagnosed at an advanced stage and has a
					poor prognosis.</description>
				<dbReference type="MIM" id="211980" />
			</disease>
			<text>The gene represented in this entry is involved in disease
				pathogenesis.</text>
		</comment>
		<comment type="disease" evidence="4 6">
			<disease id="DI-01594">
				<name>Familial non-Hodgkin lymphoma</name>
				<acronym>NHL</acronym>
				<description>Cancer that starts in cells of the lymph system, which
					is part of the body's immune system. NHLs can occur at any age and
					are often marked by enlarged lymph nodes, fever and weight loss.
				</description>
				<dbReference type="MIM" id="605027" />
			</disease>
			<text>The gene represented in this entry is involved in disease
				pathogenesis.</text>
		</comment>
		<comment type="disease" evidence="4">
			<disease id="DI-01318">
				<name>Cardiofaciocutaneous syndrome</name>
				<acronym>CFC syndrome</acronym>
				<description>Characterized by a distinctive facial appearance, heart
					defects and mental retardation. Heart defects include pulmonic
					stenosis, atrial septal defects and hypertrophic cardiomyopathy.
					Some affected individuals present with ectodermal abnormalities
					such as sparse, friable hair, hyperkeratotic skin lesions and a
					generalized ichthyosis-like condition. Typical facial features are
					similar to Noonan syndrome. They include high forehead with
					bitemporal constriction, hypoplastic supraorbital ridges,
					downslanting palpebral fissures, a depressed nasal bridge, and
					posteriorly angulated ears with prominent helices. The inheritance
					of CFC syndrome is autosomal dominant.</description>
				<dbReference type="MIM" id="115150" />
			</disease>
			<text>The disease is caused by mutations affecting the gene
				represented in this entry.</text>
		</comment>
		<comment type="disease" evidence="4 7">
			<disease id="DI-02990">
				<name>Noonan syndrome 7</name>
				<acronym>NS7</acronym>
				<description>A syndrome characterized by facial dysmorphic features
					such as hypertelorism, a downward eyeslant and low-set posteriorly
					rotated ears. Other features can include short stature, a short
					neck with webbing or redundancy of skin, cardiac anomalies,
					deafness, motor delay and variable intellectual deficits.
				</description>
				<dbReference type="MIM" id="613706" />
			</disease>
			<text>The disease is caused by mutations affecting the gene
				represented in this entry.</text>
		</comment>
		<comment type="disease" evidence="4 7">
			<disease id="DI-02991">
				<name>LEOPARD syndrome 3</name>
				<acronym>LEOPARD3</acronym>
				<description>A disorder characterized by lentigines,
					electrocardiographic conduction abnormalities, ocular
					hypertelorism, pulmonic stenosis, abnormalities of genitalia,
					retardation of growth, and sensorineural deafness.</description>
				<dbReference type="MIM" id="613707" />
			</disease>
			<text>The disease is caused by mutations affecting the gene
				represented in this entry.</text>
		</comment>
		<comment type="disease" evidence="4">
			<text>A chromosomal aberration involving BRAF is found in pilocytic
				astrocytomas. A tandem duplication of 2 Mb at 7q34 leads to the
				expression of a KIAA1549-BRAF fusion protein with a constitutive
				kinase activity and inducing cell transformation.</text>
		</comment>
		<comment type="similarity">
			<text>Belongs to the protein kinase superfamily. TKL Ser/Thr protein
				kinase family. RAF subfamily.</text>
		</comment>
		<comment type="similarity">
			<text>Contains 1 phorbol-ester/DAG-type zinc finger.</text>
		</comment>
		<comment type="similarity">
			<text>Contains 1 protein kinase domain.</text>
		</comment>
		<comment type="similarity">
			<text>Contains 1 RBD (Ras-binding) domain.</text>
		</comment>
		<comment type="sequence caution">
			<conflict type="erroneous gene model prediction">
				<sequence resource="EMBL-CDS" id="AAD43193" version="1" />
			</conflict>
		</comment>
		<comment type="sequence caution">
			<conflict type="erroneous initiation">
				<sequence resource="EMBL-CDS" id="CAQ43111" version="1" />
			</conflict>
			<text>Translation N-terminally shortened.</text>
		</comment>
		<comment type="sequence caution">
			<conflict type="erroneous initiation">
				<sequence resource="EMBL-CDS" id="CAQ43112" version="1" />
			</conflict>
			<text>Translation N-terminally shortened.</text>
		</comment>
		<comment type="sequence caution">
			<conflict type="erroneous initiation">
				<sequence resource="EMBL-CDS" id="CAQ43113" version="1" />
			</conflict>
			<text>Translation N-terminally shortened.</text>
		</comment>
		<comment type="sequence caution">
			<conflict type="erroneous initiation">
				<sequence resource="EMBL-CDS" id="CAQ43114" version="1" />
			</conflict>
			<text>Translation N-terminally shortened.</text>
		</comment>
		<comment type="sequence caution">
			<conflict type="erroneous initiation">
				<sequence resource="EMBL-CDS" id="CAQ43115" version="1" />
			</conflict>
			<text>Translation N-terminally shortened.</text>
		</comment>
		<comment type="sequence caution">
			<conflict type="erroneous initiation">
				<sequence resource="EMBL-CDS" id="CAQ43116" version="1" />
			</conflict>
			<text>Translation N-terminally shortened.</text>
		</comment>
		<comment type="alternative products">
			<event type="alternative splicing"/>
			<isoform>
				<id>P66666-2</id>
				<name>Fake isoform</name>
				<sequence type="displayed"/>
			</isoform>
		</comment>
		<comment type="online information"
			name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
			<link uri="http://atlasgeneticsoncology.org/Genes/BRAFID828.html" />
		</comment>
		<comment type="online information" name="GeneReviews">
			<link uri="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/BRAF" />
		</comment>
		<dbReference type="EC" id="2.7.11.1" />
		<dbReference type="EMBL" id="M95712">
			<property type="protein sequence ID" value="AAA35609.2" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="EMBL" id="AC006344">
			<property type="protein sequence ID" value="AAD43193.1" />
			<property type="status" value="ALT_SEQ" />
			<property type="molecule type" value="Genomic_DNA" />
		</dbReference>
		<dbReference type="EMBL" id="EU600171">
			<property type="protein sequence ID" value="ACD11489.1" />
			<property type="molecule type" value="Genomic_DNA" />
		</dbReference>
		<dbReference type="EMBL" id="AC006347">
			<property type="protein sequence ID" value="AAD15551.1" />
			<property type="molecule type" value="Genomic_DNA" />
		</dbReference>
		<dbReference type="EMBL" id="CH236950">
			<property type="protein sequence ID" value="EAL24023.1" />
			<property type="molecule type" value="Genomic_DNA" />
		</dbReference>
		<dbReference type="EMBL" id="BC101757">
			<property type="protein sequence ID" value="AAI01758.1" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="EMBL" id="BC112079">
			<property type="protein sequence ID" value="AAI12080.1" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="EMBL" id="X65187">
			<property type="protein sequence ID" value="CAA46301.1" />
			<property type="molecule type" value="Genomic_DNA" />
		</dbReference>
		<dbReference type="EMBL" id="M21001">
			<property type="protein sequence ID" value="AAA96495.1" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="EMBL" id="AM989472">
			<property type="protein sequence ID" value="CAQ43111.1" />
			<property type="status" value="ALT_INIT" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="EMBL" id="AM989473">
			<property type="protein sequence ID" value="CAQ43112.1" />
			<property type="status" value="ALT_INIT" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="EMBL" id="AM989474">
			<property type="protein sequence ID" value="CAQ43113.1" />
			<property type="status" value="ALT_INIT" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="EMBL" id="AM989475">
			<property type="protein sequence ID" value="CAQ43114.1" />
			<property type="status" value="ALT_INIT" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="EMBL" id="AM989476">
			<property type="protein sequence ID" value="CAQ43115.1" />
			<property type="status" value="ALT_INIT" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="EMBL" id="AM989477">
			<property type="protein sequence ID" value="CAQ43116.1" />
			<property type="status" value="ALT_INIT" />
			<property type="molecule type" value="mRNA" />
		</dbReference>
		<dbReference type="IPI" id="IPI00303797" />
		<dbReference type="PIR" id="A57977">
			<property type="entry name" value="TVHUBF" />
		</dbReference>
		<dbReference type="RefSeq" id="NP_004324.2">
			<property type="nucleotide sequence ID" value="NM_004333.4" />
		</dbReference>
		<dbReference type="UniGene" id="Hs.550061" />
		<dbReference type="PDB" id="1UWH">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.95" />
			<property type="chains" value="A/B=448-723" />
		</dbReference>
		<dbReference type="PDB" id="1UWJ">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.50" />
			<property type="chains" value="A/B=448-723" />
		</dbReference>
		<dbReference type="PDB" id="2FB8">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.90" />
			<property type="chains" value="A/B=445-723" />
		</dbReference>
		<dbReference type="PDB" id="2L05">
			<property type="method" value="NMR" />
			<property type="chains" value="A=149-232" />
		</dbReference>
		<dbReference type="PDB" id="3C4C">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.57" />
			<property type="chains" value="A/B=444-719" />
		</dbReference>
		<dbReference type="PDB" id="3D4Q">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.80" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3IDP">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.70" />
			<property type="chains" value="A/B=434-727" />
		</dbReference>
		<dbReference type="PDB" id="3II5">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.79" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3NY5">
			<property type="method" value="X-ray" />
			<property type="resolution" value="1.99" />
			<property type="chains" value="A/B/C/D=153-237" />
		</dbReference>
		<dbReference type="PDB" id="3OG7">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.45" />
			<property type="chains" value="A/B=449-766" />
		</dbReference>
		<dbReference type="PDB" id="3PPJ">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.70" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3PPK">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.00" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3PRF">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.90" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3PRI">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.50" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3PSB">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.40" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3PSD">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.60" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3Q4C">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.20" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3Q96">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.10" />
			<property type="chains" value="A/B=446-727" />
		</dbReference>
		<dbReference type="PDB" id="3SKC">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.20" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3TV4">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.40" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="3TV6">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.30" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="4DBN">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.15" />
			<property type="chains" value="A/B=445-726" />
		</dbReference>
		<dbReference type="PDB" id="4E26">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.55" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="4E4X">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.60" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="4EHE">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.30" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="4EHG">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.50" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="4FK3">
			<property type="method" value="X-ray" />
			<property type="resolution" value="2.65" />
			<property type="chains" value="A/B=444-719" />
		</dbReference>
		<dbReference type="PDB" id="4G9C">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.50" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="4G9R">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.20" />
			<property type="chains" value="A/B=432-726" />
		</dbReference>
		<dbReference type="PDB" id="4H58">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.10" />
			<property type="chains" value="A/B/C=448-722" />
		</dbReference>
		<dbReference type="PDB" id="4JVG">
			<property type="method" value="X-ray" />
			<property type="resolution" value="3.09" />
			<property type="chains" value="A/B/C/D=444-719" />
		</dbReference>
		<dbReference type="PDBsum" id="1UWH" />
		<dbReference type="PDBsum" id="1UWJ" />
		<dbReference type="PDBsum" id="2FB8" />
		<dbReference type="PDBsum" id="2L05" />
		<dbReference type="PDBsum" id="3C4C" />
		<dbReference type="PDBsum" id="3D4Q" />
		<dbReference type="PDBsum" id="3IDP" />
		<dbReference type="PDBsum" id="3II5" />
		<dbReference type="PDBsum" id="3NY5" />
		<dbReference type="PDBsum" id="3OG7" />
		<dbReference type="PDBsum" id="3PPJ" />
		<dbReference type="PDBsum" id="3PPK" />
		<dbReference type="PDBsum" id="3PRF" />
		<dbReference type="PDBsum" id="3PRI" />
		<dbReference type="PDBsum" id="3PSB" />
		<dbReference type="PDBsum" id="3PSD" />
		<dbReference type="PDBsum" id="3Q4C" />
		<dbReference type="PDBsum" id="3Q96" />
		<dbReference type="PDBsum" id="3SKC" />
		<dbReference type="PDBsum" id="3TV4" />
		<dbReference type="PDBsum" id="3TV6" />
		<dbReference type="PDBsum" id="4DBN" />
		<dbReference type="PDBsum" id="4E26" />
		<dbReference type="PDBsum" id="4E4X" />
		<dbReference type="PDBsum" id="4EHE" />
		<dbReference type="PDBsum" id="4EHG" />
		<dbReference type="PDBsum" id="4FK3" />
		<dbReference type="PDBsum" id="4G9C" />
		<dbReference type="PDBsum" id="4G9R" />
		<dbReference type="PDBsum" id="4H58" />
		<dbReference type="PDBsum" id="4JVG" />
		<dbReference type="ProteinModelPortal" id="P15056" />
		<dbReference type="DIP" id="DIP-1045N" />
		<dbReference type="IntAct" id="P15056">
			<property type="interactions" value="24" />
		</dbReference>
		<dbReference type="MINT" id="MINT-1574728" />
		<dbReference type="STRING" id="9606.ENSP00000288602" />
		<dbReference type="PhosphoSite" id="P15056" />
		<dbReference type="DMDM" id="50403720" />
		<dbReference type="PaxDb" id="P15056" />
		<dbReference type="PRIDE" id="P15056" />
		<dbReference type="DNASU" id="673" />
		<dbReference type="Ensembl" id="ENST00000288602">
			<property type="protein sequence ID" value="ENSP00000288602" />
			<property type="gene ID" value="ENSG00000157764" />
		</dbReference>
		<dbReference type="GeneID" id="673" />
		<dbReference type="KEGG" id="hsa:673" />
		<dbReference type="UCSC" id="uc003vwc.4">
			<property type="organism name" value="human" />
		</dbReference>
		<dbReference type="CTD" id="673" />
		<dbReference type="GeneCards" id="GC07M140424" />
		<dbReference type="H-InvDB" id="HIX0167822" />
		<dbReference type="HGNC" id="HGNC:1097">
			<property type="gene designation" value="BRAF" />
		</dbReference>
		<dbReference type="HPA" id="CAB004552" />
		<dbReference type="HPA" id="HPA001328" />
		<dbReference type="MIM" id="114500">
			<property type="type" value="phenotype" />
		</dbReference>
		<dbReference type="MIM" id="115150">
			<property type="type" value="phenotype" />
		</dbReference>
		<dbReference type="MIM" id="164757">
			<property type="type" value="gene" />
		</dbReference>
		<dbReference type="MIM" id="211980">
			<property type="type" value="phenotype" />
		</dbReference>
		<dbReference type="MIM" id="605027">
			<property type="type" value="phenotype" />
		</dbReference>
		<dbReference type="MIM" id="613706">
			<property type="type" value="phenotype" />
		</dbReference>
		<dbReference type="MIM" id="613707">
			<property type="type" value="phenotype" />
		</dbReference>
		<dbReference type="neXtProt" id="NX_P15056" />
		<dbReference type="Orphanet" id="1340">
			<property type="disease" value="Cardiofaciocutaneous syndrome" />
		</dbReference>
		<dbReference type="Orphanet" id="58017">
			<property type="disease" value="Hairy cell leukemia" />
		</dbReference>
		<dbReference type="Orphanet" id="99872">
			<property type="disease" value="Hashimoto-Pritzker syndrome" />
		</dbReference>
		<dbReference type="Orphanet" id="500">
			<property type="disease" value="LEOPARD syndrome" />
		</dbReference>
		<dbReference type="Orphanet" id="648">
			<property type="disease" value="Noonan syndrome" />
		</dbReference>
		<dbReference type="PharmGKB" id="PA25408" />
		<dbReference type="eggNOG" id="COG0515" />
		<dbReference type="HOVERGEN" id="HBG001886" />
		<dbReference type="InParanoid" id="P15056" />
		<dbReference type="KO" id="K04365" />
		<dbReference type="OMA" id="DWEIPEG" />
		<dbReference type="OrthoDB" id="EOG41G33M" />
		<dbReference type="BRENDA" id="2.7.10.2">
			<property type="organism ID" value="2681" />
		</dbReference>
		<dbReference type="Pathway_Interaction_DB" id="cd8tcrdownstreampathway">
			<property type="pathway name" value="Downstream signaling in naive CD8+ T cells" />
		</dbReference>
		<dbReference type="Pathway_Interaction_DB" id="tcrraspathway">
			<property type="pathway name" value="Ras signaling in the CD4+ TCR pathway" />
		</dbReference>
		<dbReference type="Pathway_Interaction_DB" id="mapktrkpathway">
			<property type="pathway name"
				value="Trk receptor signaling mediated by the MAPK pathway" />
		</dbReference>
		<dbReference type="Reactome" id="REACT_111102">
			<property type="pathway name" value="Signal Transduction" />
		</dbReference>
		<dbReference type="Reactome" id="REACT_116125">
			<property type="pathway name" value="Disease" />
		</dbReference>
		<dbReference type="Reactome" id="REACT_13685">
			<property type="pathway name" value="Neuronal System" />
		</dbReference>
		<dbReference type="SignaLink" id="P15056" />
		<dbReference type="BindingDB" id="P15056" />
		<dbReference type="ChEMBL" id="CHEMBL5145" />
		<dbReference type="ChiTaRS" id="BRAF">
			<property type="organism name" value="human" />
		</dbReference>
		<dbReference type="DrugBank" id="DB00398">
			<property type="generic name" value="Sorafenib" />
		</dbReference>
		<dbReference type="EvolutionaryTrace" id="P15056" />
		<dbReference type="GeneWiki" id="BRAF_(gene)" />
		<dbReference type="GenomeRNAi" id="673" />
		<dbReference type="NextBio" id="2776" />
		<dbReference type="PMAP-CutDB" id="P15056" />
		<dbReference type="ArrayExpress" id="P15056" />
		<dbReference type="Bgee" id="P15056" />
		<dbReference type="CleanEx" id="HS_BRAF" />
		<dbReference type="Genevestigator" id="P15056" />
		<dbReference type="GO" id="GO:0005829">
			<property type="term" value="C:cytosol" />
			<property type="evidence" value="TAS:Reactome" />
		</dbReference>
		<dbReference type="GO" id="GO:0005634">
			<property type="term" value="C:nucleus" />
			<property type="evidence" value="IEA:UniProtKB-SubCell" />
		</dbReference>
		<dbReference type="GO" id="GO:0005886">
			<property type="term" value="C:plasma membrane" />
			<property type="evidence" value="TAS:Reactome" />
		</dbReference>
		<dbReference type="GO" id="GO:0005524">
			<property type="term" value="F:ATP binding" />
			<property type="evidence" value="IEA:UniProtKB-KW" />
		</dbReference>
		<dbReference type="GO" id="GO:0005509">
			<property type="term" value="F:calcium ion binding" />
			<property type="evidence" value="IDA:BHF-UCL" />
		</dbReference>
		<dbReference type="GO" id="GO:0004674">
			<property type="term" value="F:protein serine/threonine kinase activity" />
			<property type="evidence" value="IDA:UniProtKB" />
		</dbReference>
		<dbReference type="GO" id="GO:0005057">
			<property type="term" value="F:receptor signaling protein activity" />
			<property type="evidence" value="IEA:InterPro" />
		</dbReference>
		<dbReference type="GO" id="GO:0000186">
			<property type="term" value="P:activation of MAPKK activity" />
			<property type="evidence" value="TAS:Reactome" />
		</dbReference>
		<dbReference type="GO" id="GO:0071277">
			<property type="term" value="P:cellular response to calcium ion" />
			<property type="evidence" value="IDA:BHF-UCL" />
		</dbReference>
		<dbReference type="GO" id="GO:0008543">
			<property type="term"
				value="P:fibroblast growth factor receptor signaling pathway" />
			<property type="evidence" value="TAS:Reactome" />
		</dbReference>
		<dbReference type="GO" id="GO:0043066">
			<property type="term" value="P:negative regulation of apoptotic process" />
			<property type="evidence" value="IDA:UniProtKB" />
		</dbReference>
		<dbReference type="GO" id="GO:0048011">
			<property type="term"
				value="P:neurotrophin TRK receptor signaling pathway" />
			<property type="evidence" value="TAS:Reactome" />
		</dbReference>
		<dbReference type="GO" id="GO:0009887">
			<property type="term" value="P:organ morphogenesis" />
			<property type="evidence" value="TAS:ProtInc" />
		</dbReference>
		<dbReference type="GO" id="GO:0070374">
			<property type="term"
				value="P:positive regulation of ERK1 and ERK2 cascade" />
			<property type="evidence" value="IDA:BHF-UCL" />
		</dbReference>
		<dbReference type="GO" id="GO:0010628">
			<property type="term" value="P:positive regulation of gene expression" />
			<property type="evidence" value="IMP:BHF-UCL" />
		</dbReference>
		<dbReference type="GO" id="GO:0033138">
			<property type="term"
				value="P:positive regulation of peptidyl-serine phosphorylation" />
			<property type="evidence" value="IDA:UniProtKB" />
		</dbReference>
		<dbReference type="GO" id="GO:0070849">
			<property type="term"
				value="P:response to epidermal growth factor stimulus" />
			<property type="evidence" value="IDA:BHF-UCL" />
		</dbReference>
		<dbReference type="GO" id="GO:0007264">
			<property type="term" value="P:small GTPase mediated signal transduction" />
			<property type="evidence" value="TAS:Reactome" />
		</dbReference>
		<dbReference type="GO" id="GO:0007268">
			<property type="term" value="P:synaptic transmission" />
			<property type="evidence" value="TAS:Reactome" />
		</dbReference>
		<dbReference type="InterPro" id="IPR020454">
			<property type="entry name" value="DAG/PE-bd" />
		</dbReference>
		<dbReference type="InterPro" id="IPR011009">
			<property type="entry name" value="Kinase-like_dom" />
		</dbReference>
		<dbReference type="InterPro" id="IPR002219">
			<property type="entry name" value="Prot_Kinase_C-like_PE/DAG-bd" />
		</dbReference>
		<dbReference type="InterPro" id="IPR000719">
			<property type="entry name" value="Prot_kinase_cat_dom" />
		</dbReference>
		<dbReference type="InterPro" id="IPR017441">
			<property type="entry name" value="Protein_kinase_ATP_BS" />
		</dbReference>
		<dbReference type="InterPro" id="IPR003116">
			<property type="entry name" value="Raf-like_ras-bd" />
		</dbReference>
		<dbReference type="InterPro" id="IPR001245">
			<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom" />
		</dbReference>
		<dbReference type="InterPro" id="IPR008271">
			<property type="entry name" value="Ser/Thr_kinase_AS" />
		</dbReference>
		<dbReference type="Pfam" id="PF00130">
			<property type="entry name" value="C1_1" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="Pfam" id="PF07714">
			<property type="entry name" value="Pkinase_Tyr" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="Pfam" id="PF02196">
			<property type="entry name" value="RBD" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="PRINTS" id="PR00008">
			<property type="entry name" value="DAGPEDOMAIN" />
		</dbReference>
		<dbReference type="SMART" id="SM00109">
			<property type="entry name" value="C1" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="SMART" id="SM00455">
			<property type="entry name" value="RBD" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="SUPFAM" id="SSF56112">
			<property type="entry name" value="Kinase_like" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="PROSITE" id="PS00107">
			<property type="entry name" value="PROTEIN_KINASE_ATP" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="PROSITE" id="PS50011">
			<property type="entry name" value="PROTEIN_KINASE_DOM" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="PROSITE" id="PS00108">
			<property type="entry name" value="PROTEIN_KINASE_ST" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="PROSITE" id="PS50898">
			<property type="entry name" value="RBD" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="PROSITE" id="PS00479">
			<property type="entry name" value="ZF_DAG_PE_1" />
			<property type="match status" value="1" />
		</dbReference>
		<dbReference type="PROSITE" id="PS50081">
			<property type="entry name" value="ZF_DAG_PE_2" />
			<property type="match status" value="1" />
		</dbReference>
		<proteinExistence type="evidence at protein level" />
		<keyword id="KW-0002">3D-structure</keyword>
		<keyword id="KW-0067">ATP-binding</keyword>
		<keyword id="KW-0007">Acetylation</keyword>
		<keyword id="KW-0122">Cardiomyopathy</keyword>
		<keyword id="KW-1003">Cell membrane</keyword>
		<keyword id="KW-0160">Chromosomal rearrangement</keyword>
		<keyword id="KW-0181">Complete proteome</keyword>
		<keyword id="KW-0963">Cytoplasm</keyword>
		<keyword id="KW-0209">Deafness</keyword>
		<keyword id="KW-0903">Direct protein sequencing</keyword>
		<keyword id="KW-0225">Disease mutation</keyword>
		<keyword id="KW-0418">Kinase</keyword>
		<keyword id="KW-0472">Membrane</keyword>
		<keyword id="KW-0479">Metal-binding</keyword>
		<keyword id="KW-0488">Methylation</keyword>
		<keyword id="KW-0547">Nucleotide-binding</keyword>
		<keyword id="KW-0539">Nucleus</keyword>
		<keyword id="KW-0597">Phosphoprotein</keyword>
		<keyword id="KW-0621">Polymorphism</keyword>
		<keyword id="KW-0656">Proto-oncogene</keyword>
		<keyword id="KW-1185">Reference proteome</keyword>
		<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
		<keyword id="KW-0808">Transferase</keyword>
		<keyword id="KW-0832">Ubl conjugation</keyword>
		<keyword id="KW-0862">Zinc</keyword>
		<keyword id="KW-0863">Zinc-finger</keyword>
		<feature type="initiator methionine" description="Removed"
			evidence="8">
			<location>
				<position position="1" />
			</location>
		</feature>
		<feature type="chain" description="Serine/threonine-protein kinase B-raf"
			id="PRO_0000085665">
			<location>
				<begin position="2" />
				<end position="766" />
			</location>
		</feature>
		<feature type="domain" description="RBD">
			<location>
				<begin position="155" />
				<end position="227" />
			</location>
		</feature>
		<feature type="domain" description="Protein kinase">
			<location>
				<begin position="457" />
				<end position="717" />
			</location>
		</feature>
		<feature type="zinc finger region" description="Phorbol-ester/DAG-type">
			<location>
				<begin position="234" />
				<end position="280" />
			</location>
		</feature>
		<feature type="nucleotide phosphate-binding region"
			description="ATP" status="by similarity">
			<location>
				<begin position="463" />
				<end position="471" />
			</location>
		</feature>
		<feature type="compositionally biased region" description="Poly-Gly">
			<location>
				<begin position="6" />
				<end position="11" />
			</location>
		</feature>
		<feature type="compositionally biased region" description="Poly-Ser">
			<location>
				<begin position="122" />
				<end position="129" />
			</location>
		</feature>
		<feature type="compositionally biased region" description="Poly-Ser">
			<location>
				<begin position="428" />
				<end position="432" />
			</location>
		</feature>
		<feature type="active site" description="Proton acceptor"
			status="by similarity">
			<location>
				<position position="576" />
			</location>
		</feature>
		<feature type="metal ion-binding site" description="Zinc 1"
			status="by similarity">
			<location>
				<position position="235" />
			</location>
		</feature>
		<feature type="metal ion-binding site" description="Zinc 2"
			status="by similarity">
			<location>
				<position position="248" />
			</location>
		</feature>
		<feature type="metal ion-binding site" description="Zinc 2"
			status="by similarity">
			<location>
				<position position="251" />
			</location>
		</feature>
		<feature type="metal ion-binding site" description="Zinc 1"
			status="by similarity">
			<location>
				<position position="261" />
			</location>
		</feature>
		<feature type="metal ion-binding site" description="Zinc 1"
			status="by similarity">
			<location>
				<position position="264" />
			</location>
		</feature>
		<feature type="metal ion-binding site" description="Zinc 2"
			status="by similarity">
			<location>
				<position position="269" />
			</location>
		</feature>
		<feature type="metal ion-binding site" description="Zinc 2"
			status="by similarity">
			<location>
				<position position="272" />
			</location>
		</feature>
		<feature type="metal ion-binding site" description="Zinc 1"
			status="by similarity">
			<location>
				<position position="280" />
			</location>
		</feature>
		<feature type="binding site" description="ATP" status="by similarity">
			<location>
				<position position="483" />
			</location>
		</feature>
		<feature type="site"
			description="Breakpoint for translocation to form KIAA1549-BRAF fusion protein">
			<location>
				<begin position="380" />
				<end position="381" />
			</location>
		</feature>
		<feature type="site"
			description="Breakpoint for translocation to form KIAA1549-BRAF fusion protein">
			<location>
				<begin position="438" />
				<end position="439" />
			</location>
		</feature>
		<feature type="modified residue" description="N-acetylalanine"
			evidence="8">
			<location>
				<position position="2" />
			</location>
		</feature>
		<feature type="modified residue" description="Phosphoserine; by SGK1"
			evidence="8 9">
			<location>
				<position position="365" />
			</location>
		</feature>
		<feature type="modified residue" description="Phosphothreonine; by autocatalysis"
			evidence="10">
			<location>
				<position position="373" />
			</location>
		</feature>
		<feature type="modified residue" description="Phosphothreonine"
			evidence="8">
			<location>
				<position position="396" />
			</location>
		</feature>
		<feature type="modified residue" description="Phosphoserine"
			evidence="8">
			<location>
				<position position="399" />
			</location>
		</feature>
		<feature type="modified residue" description="Phosphothreonine"
			evidence="8 11 12">
			<location>
				<position position="401" />
			</location>
		</feature>
		<feature type="modified residue" description="Phosphoserine"
			evidence="12">
			<location>
				<position position="446" />
			</location>
		</feature>
		<feature type="modified residue" description="Phosphoserine"
			evidence="12">
			<location>
				<position position="447" />
			</location>
		</feature>
		<feature type="modified residue" description="Omega-N-methylarginine; by PRMT5"
			evidence="2">
			<location>
				<position position="671" />
			</location>
		</feature>
		<feature type="modified residue" description="Phosphoserine"
			evidence="8 12 13">
			<location>
				<position position="729" />
			</location>
		</feature>
		<feature type="modified residue" description="Phosphothreonine; by MAPK1"
			evidence="1">
			<location>
				<position position="753" />
			</location>
		</feature>
		<feature type="sequence variant" description="In a patient with Noonan syndrome."
			id="VAR_058620" evidence="7">
			<original>T</original>
			<variation>M</variation>
			<location>
				<position position="241" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome and LEOPARD3."
			id="VAR_058621" evidence="7 14">
			<original>T</original>
			<variation>P</variation>
			<location>
				<position position="241" />
			</location>
		</feature>
		<feature type="sequence variant" description="In a patient with Noonan syndrome."
			id="VAR_058622" evidence="7">
			<original>T</original>
			<variation>R</variation>
			<location>
				<position position="241" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_065171" evidence="14">
			<original>T</original>
			<variation>P</variation>
			<location>
				<position position="244" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_058623" evidence="7">
			<original>L</original>
			<variation>F</variation>
			<location>
				<position position="245" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_026113" evidence="7 14 15">
			<original>A</original>
			<variation>P</variation>
			<location>
				<position position="246" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_026114" evidence="7 14 15 16">
			<original>Q</original>
			<variation>R</variation>
			<location>
				<position position="257" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_065172" evidence="14">
			<original>Q</original>
			<variation>K</variation>
			<location>
				<position position="262" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_058624" evidence="7">
			<original>E</original>
			<variation>K</variation>
			<location>
				<position position="275" />
			</location>
		</feature>
		<feature type="sequence variant" description="In dbSNP:rs34776339."
			id="VAR_040391" evidence="17">
			<original>P</original>
			<variation>S</variation>
			<location>
				<position position="301" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CRC." id="VAR_018613">
			<original>R</original>
			<variation>I</variation>
			<location>
				<position position="462" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CRC." id="VAR_018614">
			<original>I</original>
			<variation>S</variation>
			<location>
				<position position="463" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CRC." id="VAR_018615">
			<original>G</original>
			<variation>E</variation>
			<location>
				<position position="464" />
			</location>
		</feature>
		<feature type="sequence variant"
			description="In a colorectal cancer cell line; elevated kinase activity; efficiently induces cell transformation."
			id="VAR_018616" evidence="18">
			<original>G</original>
			<variation>V</variation>
			<location>
				<position position="464" />
			</location>
		</feature>
		<feature type="sequence variant" description="In melanoma."
			id="VAR_018617" evidence="18">
			<original>G</original>
			<variation>A</variation>
			<location>
				<position position="466" />
			</location>
		</feature>
		<feature type="sequence variant" description="In melanoma."
			id="VAR_018618" evidence="18">
			<original>G</original>
			<variation>E</variation>
			<location>
				<position position="466" />
			</location>
		</feature>
		<feature type="sequence variant" description="In LNCR." id="VAR_018512"
			evidence="5 18">
			<original>G</original>
			<variation>V</variation>
			<location>
				<position position="466" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_035096" evidence="16">
			<original>S</original>
			<variation>A</variation>
			<location>
				<position position="467" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_035097" evidence="14 16">
			<original>F</original>
			<variation>S</variation>
			<location>
				<position position="468" />
			</location>
		</feature>
		<feature type="sequence variant"
			description="In NHL; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation."
			id="VAR_018620" evidence="6 17 18">
			<original>G</original>
			<variation>A</variation>
			<location>
				<position position="469" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome and colon cancer."
			id="VAR_018621" evidence="7 14 15 16 18">
			<original>G</original>
			<variation>E</variation>
			<location>
				<position position="469" />
			</location>
		</feature>
		<feature type="sequence variant" description="In NHL." id="VAR_018622"
			evidence="6">
			<original>G</original>
			<variation>R</variation>
			<location>
				<position position="469" />
			</location>
		</feature>
		<feature type="sequence variant"
			description="In a colorectal adenocarcinoma sample; somatic mutation."
			id="VAR_040392" evidence="17">
			<original>G</original>
			<variation>V</variation>
			<location>
				<position position="469" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_026115" evidence="7 15 16">
			<original>L</original>
			<variation>F</variation>
			<location>
				<position position="485" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_026116" evidence="14 15 16">
			<original>K</original>
			<variation>E</variation>
			<location>
				<position position="499" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_058625" evidence="7 14">
			<original>K</original>
			<variation>N</variation>
			<location>
				<position position="499" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_026117" evidence="15 16">
			<original>E</original>
			<variation>G</variation>
			<location>
				<position position="501" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_026118" evidence="7 15 16">
			<original>E</original>
			<variation>K</variation>
			<location>
				<position position="501" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_058626" evidence="7">
			<original>L</original>
			<variation>P</variation>
			<location>
				<position position="525" />
			</location>
		</feature>
		<feature type="sequence variant" description="In NS7." id="VAR_058627"
			evidence="7">
			<original>W</original>
			<variation>C</variation>
			<location>
				<position position="531" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_065173" evidence="14">
			<original>N</original>
			<variation>D</variation>
			<location>
				<position position="580" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_026119" evidence="14 15 16">
			<original>N</original>
			<variation>D</variation>
			<location>
				<position position="581" />
			</location>
		</feature>
		<feature type="sequence variant"
			description="In a colorectal adenocarcinoma sample; somatic mutation."
			id="VAR_040393" evidence="17">
			<original>N</original>
			<variation>S</variation>
			<location>
				<position position="581" />
			</location>
		</feature>
		<feature type="sequence variant" description="In ovarian cancer."
			id="VAR_018623" evidence="18">
			<original>E</original>
			<variation>K</variation>
			<location>
				<position position="586" />
			</location>
		</feature>
		<feature type="sequence variant" description="In NHL." id="VAR_018624"
			evidence="6">
			<original>D</original>
			<variation>G</variation>
			<location>
				<position position="594" />
			</location>
		</feature>
		<feature type="sequence variant" description="In colon cancer and CFC syndrome."
			id="VAR_018625" evidence="7 14 16 18">
			<original>F</original>
			<variation>L</variation>
			<location>
				<position position="595" />
			</location>
		</feature>
		<feature type="sequence variant"
			description="In a colorectal adenocarcinoma sample; somatic mutation."
			id="VAR_018626" evidence="17 18">
			<original>G</original>
			<variation>R</variation>
			<location>
				<position position="596" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_035098" evidence="16">
			<original>G</original>
			<variation>V</variation>
			<location>
				<position position="596" />
			</location>
		</feature>
		<feature type="sequence variant"
			description="In LNCR; also found in an ovarian serous carcinoma sample; somatic mutation."
			id="VAR_018513" evidence="5 17 18">
			<original>L</original>
			<variation>R</variation>
			<location>
				<position position="597" />
			</location>
		</feature>
		<feature type="sequence variant"
			description="In NS7; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation."
			id="VAR_018627" evidence="7 17 18">
			<original>L</original>
			<variation>V</variation>
			<location>
				<position position="597" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_058628" evidence="7">
			<original>T</original>
			<variation>R</variation>
			<location>
				<position position="599" />
			</location>
		</feature>
		<feature type="sequence variant"
			description="In a melanoma cell line; requires 2 nucleotide substitutions."
			id="VAR_018628" evidence="18">
			<original>V</original>
			<variation>D</variation>
			<location>
				<position position="600" />
			</location>
		</feature>
		<feature type="sequence variant"
			description="In CRC; also found in sarcoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis; loss of regulation by PMRT5."
			id="VAR_018629">
			<original>V</original>
			<variation>E</variation>
			<location>
				<position position="600" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CRC." id="VAR_018630">
			<original>K</original>
			<variation>E</variation>
			<location>
				<position position="601" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_058629" evidence="7">
			<original>K</original>
			<variation>Q</variation>
			<location>
				<position position="601" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_058630" evidence="7">
			<original>D</original>
			<variation>E</variation>
			<location>
				<position position="638" />
			</location>
		</feature>
		<feature type="sequence variant" description="In CFC syndrome."
			id="VAR_058631" evidence="7">
			<original>Q</original>
			<variation>R</variation>
			<location>
				<position position="709" />
			</location>
		</feature>
		<feature type="mutagenesis site"
			description="Increased kinase activity and stability in response to EGF treatment."
			evidence="2">
			<original>R</original>
			<variation>K</variation>
			<location>
				<position position="671" />
			</location>
		</feature>
		<feature type="sequence conflict" description="In Ref. 11; AAA96495."
			ref="11">
			<original>H</original>
			<variation>D</variation>
			<location>
				<position position="766" />
			</location>
		</feature>
		<evidence key="1" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="19710016" />
			</source>
		</evidence>
		<evidence key="2" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="21917714" />
			</source>
		</evidence>
		<evidence key="3" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="22628551" />
			</source>
		</evidence>
		<evidence key="4" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="18974108" />
			</source>
		</evidence>
		<evidence key="5" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="12460919" />
			</source>
		</evidence>
		<evidence key="6" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="14612909" />
			</source>
		</evidence>
		<evidence key="7" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="19206169" />
			</source>
		</evidence>
		<evidence key="8" type="ECO:0000006">
			<source ref="8" />
		</evidence>
		<evidence key="9" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="11410590" />
			</source>
		</evidence>
		<evidence key="10" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="1508179" />
			</source>
		</evidence>
		<evidence key="11" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="16964243" />
			</source>
		</evidence>
		<evidence key="12" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="18669648" />
			</source>
		</evidence>
		<evidence key="13" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="21406692" />
			</source>
		</evidence>
		<evidence key="14" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="18042262" />
			</source>
		</evidence>
		<evidence key="15" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="16474404" />
			</source>
		</evidence>
		<evidence key="16" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="16439621" />
			</source>
		</evidence>
		<evidence key="17" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="17344846" />
			</source>
		</evidence>
		<evidence key="18" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="12068308" />
			</source>
		</evidence>
		<sequence length="766" mass="84437" checksum="0798C2AAB487E813"
			modified="2004-07-19" version="4">
			MAALSGGGGGGAEPGQALFNGDMEPEAGAGAGAAASSAADPAIPEEVWNIKQMIKLTQEH
			IEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSSASMDTV
			TSSSSSSLSVLPSSLSVFQNPTDVARSNPKSPQKPIVRVFLPNKQRTVVPARCGVTVRDS
			LKKALMMRGLIPECCAVYRIQDGEKKPIGWDTDISWLTGEELHVEVLENVPLTTHNFVRK
			TFFTLAFCDFCRKLLFQGFRCQTCGYKFHQRCSTEVPLMCVNYDQLDLLFVSKFFEHHPI
			PQEEASLAETALTSGSSPSAPASDSIGPQILTSPSPSKSIPIPQPFRPADEDHRNQFGQR
			DRSSSAPNVHINTIEPVNIDDLIRDQGFRGDGGSTTGLSATPPASLPGSLTNVKALQKSP
			GPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDV
			AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHH
			LHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV
			KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN
			NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS
			LPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH
		</sequence>
	</entry>
	<entry dataset="Swiss-Prot" created="2009-03-03" modified="2012-10-03" version="11">
		<accession>P0C8T7</accession>
		<name>BR2PE_RANPC</name>
		<protein>
			<recommendedName>
				<fullName>Brevinin-2PTe</fullName>
			</recommendedName>
		</protein>
		<organism>
			<name type="scientific">Rana picturata</name>
			<name type="common">Malaysian fire frog</name>
			<name type="synonym">Hylarana picturata</name>
			<dbReference type="NCBI Taxonomy" id="395594"/>
			<lineage>
				<taxon>Eukaryota</taxon>
				<taxon>Metazoa</taxon>
				<taxon>Chordata</taxon>
				<taxon>Craniata</taxon>
				<taxon>Vertebrata</taxon>
				<taxon>Euteleostomi</taxon>
				<taxon>Amphibia</taxon>
				<taxon>Batrachia</taxon>
				<taxon>Anura</taxon>
				<taxon>Neobatrachia</taxon>
				<taxon>Ranoidea</taxon>
				<taxon>Ranidae</taxon>
				<taxon>Hylarana</taxon>
			</lineage>
		</organism>
		<dbReference type="HOVERGEN" id="HBG107533"/>
		<dbReference type="GO" id="GO:0005576">
			<property type="term" value="C:extracellular region"/>
			<property type="evidence" value="IEA:UniProtKB-SubCell"/>
		</dbReference>
		<dbReference type="GO" id="GO:0042742">
			<property type="term" value="P:defense response to bacterium"/>
			<property type="evidence" value="IEA:UniProtKB-KW"/>
		</dbReference>
		<dbReference type="InterPro" id="IPR012521">
			<property type="entry name" value="Antimicrobial_frog_2"/>
		</dbReference>
		<dbReference type="Pfam" id="PF08023">
			<property type="entry name" value="Antimicrobial_2"/>
			<property type="match status" value="1"/>
		</dbReference>
		<proteinExistence type="evidence at protein level"/>
		<sequence length="33" mass="3405" checksum="AFF71E7E3DF6883D" modified="2009-03-03" version="1">GFLDSFKNAMIGVAKSVGKTALSTLACKIDKSC</sequence>
	</entry>
	<entry dataset="Swiss-Prot" created="2007-01-09" modified="2012-10-03" version="13">
		<accession>P84858</accession>
		<name>TEMP_RANGU</name>
		<protein>
			<recommendedName>
				<fullName>Temporin-GH</fullName>
			</recommendedName>
			<alternativeName>
				<fullName>AMP-5</fullName>
			</alternativeName>
		</protein>
		<organism>
			<name type="scientific">Rana guentheri</name>
			<name type="common">Gunther's frog</name>
			<dbReference type="NCBI Taxonomy" id="110109"/>
			<lineage>
				<taxon>Eukaryota</taxon>
				<taxon>Metazoa</taxon>
				<taxon>Chordata</taxon>
				<taxon>Craniata</taxon>
				<taxon>Vertebrata</taxon>
				<taxon>Euteleostomi</taxon>
				<taxon>Amphibia</taxon>
				<taxon>Batrachia</taxon>
				<taxon>Anura</taxon>
				<taxon>Neobatrachia</taxon>
				<taxon>Ranoidea</taxon>
				<taxon>Ranidae</taxon>
				<taxon>Hylarana</taxon>
			</lineage>
		</organism>
		<dbReference type="GO" id="GO:0005576">
			<property type="term" value="C:extracellular region"/>
			<property type="evidence" value="IEA:UniProtKB-SubCell"/>
		</dbReference>
		<dbReference type="GO" id="GO:0042742">
			<property type="term" value="P:defense response to bacterium"/>
			<property type="evidence" value="IEA:UniProtKB-KW"/>
		</dbReference>
		<proteinExistence type="evidence at protein level"/>
		<feature type="peptide" description="Temporin-GH" id="PRO_0000271188">
			<location>
				<begin position="1"/>
				<end position="13"/>
			</location>
		</feature>
		<feature type="modified residue" description="Leucine amide" evidence="1">
			<location>
				<position position="13"/>
			</location>
		</feature>
		<sequence length="13" mass="1441" checksum="D70518BB9A83D879" modified="2007-01-09" version="1">FLPLLFGAISHLL</sequence>
	</entry>
</uniprot>